<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>PILMAN &#187; opposes</title>
	<atom:link href="http://www.tapanray.in/tag/opposes/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.tapanray.in</link>
	<description>A Tapan Ray Website</description>
	<lastBuildDate>Sun, 22 Mar 2026 10:59:18 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.4.2</generator>
		<item>
		<title>Marketing Off-label Use of Drugs: A Path Much Abused?</title>
		<link>http://www.tapanray.in/marketing-off-label-use-of-drugs-a-path-much-abused/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=marketing-off-label-use-of-drugs-a-path-much-abused</link>
		<comments>http://www.tapanray.in/marketing-off-label-use-of-drugs-a-path-much-abused/#comments</comments>
		<pubDate>Mon, 30 Nov 2015 00:00:23 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[abused]]></category>
		<category><![CDATA[ADE]]></category>
		<category><![CDATA[adverse]]></category>
		<category><![CDATA[cities]]></category>
		<category><![CDATA[common]]></category>
		<category><![CDATA[DCGI]]></category>
		<category><![CDATA[drugs]]></category>
		<category><![CDATA[electronic]]></category>
		<category><![CDATA[events]]></category>
		<category><![CDATA[France]]></category>
		<category><![CDATA[Health]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[industry]]></category>
		<category><![CDATA[Internal]]></category>
		<category><![CDATA[Italy]]></category>
		<category><![CDATA[JAMA]]></category>
		<category><![CDATA[marketing]]></category>
		<category><![CDATA[medicine]]></category>
		<category><![CDATA[Medicines]]></category>
		<category><![CDATA[methods]]></category>
		<category><![CDATA[off-label]]></category>
		<category><![CDATA[opposes]]></category>
		<category><![CDATA[path]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[records]]></category>
		<category><![CDATA[Safety]]></category>
		<category><![CDATA[smart]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[Tapan Ray]]></category>
		<category><![CDATA[usages]]></category>
		<category><![CDATA[use]]></category>
		<category><![CDATA[USFDA]]></category>

		<guid isPermaLink="false">http://www.tapanray.in/?p=7296</guid>
		<description><![CDATA[As many would know, prescribing any medicine for disease conditions that are not approved by the drug approving authorities while granting its marketing approval, is generally termed as ‘off-label’ use of drugs. It is also a usual practice in most &#8230; <a href="http://www.tapanray.in/marketing-off-label-use-of-drugs-a-path-much-abused/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/marketing-off-label-use-of-drugs-a-path-much-abused/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
